Device Trial Radar · NCT06078878
Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter
Last checked: Nov 20, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Feb 13, 2023
Primary completion
Sep 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Gentuity, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 12, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective, single arm, unblinded, and open-label study. The study is designed to evaluate the use of the Gentuity Neurovascular Imaging System in patients undergoing elective neurointerventional diagnostic procedures.
Conditions
- Anatomy
Interventions
HF-OCT Imaging System with Vis-M Micro-Imaging CatheterDevice
Subjects undergo HF-OCT imaging of the desired intravascular segement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device SafetyTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clínica La Sagrada Familia
Buenos Aires, Argentina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.